EFB Dengue Literature Review

IL-21

8 min read

IL-21

Overview

Interleukin-21 (IL-21) is a type I cytokine produced by activated CD4⁺ T cells — both follicular helper T cells (Tfh) and peripheral helper T cells (Tph). IL-21 is a potent driver of B cell differentiation into antibody-secreting cells (ASCs/plasmablasts), promoting plasma cell gene expression (BLIMP-1/IRF4) and immunoglobulin secretion. In the extrafollicular B cell pathway, IL-21 is one of the three key signals (alongside TLR7 and IFN-γ) required for the aNAV → DN2 → plasmablast differentiation cascade.

Key Points from Literature

  • IL-21 is required for EF differentiation in vitro: The Jenks2018 rNAV→aNAV→DN2→plasmablast differentiation protocol requires TLR7 (R848) + IFN-γ + IL-21. Removing IL-21 abolishes plasmablast generation. IL-21 cooperates with TLR7 signalling; BCR engagement is not required (see Jenks2018 - DN2 B Cells and EF Pathway in SLE, in vitro differentiation).

  • IL-21 is produced by Tph cells in acute dengue at levels comparable to cTfh: Intracellular cytokine staining shows CXCR5⁻PD-1⁺ (Tph) cells produce IL-21 at frequencies comparable to CXCR5⁺PD-1⁺ (cTfh) cells. This identifies Tph as a major IL-21 source in the extrafollicular context of dengue (see Ansari2025 - Peripheral T Helper Subset Drives B Cell Response in Dengue, n=170 cohort).

  • Blocking IL-21 reduces Tph-driven plasmablast output by ~60%: In T-B coculture experiments, anti-IL-21 blocking antibody substantially reduces but does not abolish plasmablast generation from memory B cells cocultured with Tph. The residual ~40% output likely reflects other Tph-derived signals (CD40L, ICOS, other cytokines) (see Ansari2025 - Peripheral T Helper Subset Drives B Cell Response in Dengue).

  • IL-21 marks the helper Tph subcluster: scRNA-seq of activated CD4⁺ T cells in dengue identified an IL-21⁺ helper Tph cluster co-expressing ICOS, MAF, and TOX2, distinct from the GZMB⁺ cytotoxic Tph cluster. This separation suggests IL-21 production is a defining feature of the B cell help-competent Tph subset (see Ansari2025 - Peripheral T Helper Subset Drives B Cell Response in Dengue, scRNA-seq, 4,361 cells).

  • IL-21 in the SLE EF programme: IL-21 is elevated in SLE and contributes to the sustained EF activation and plasmablast expansion that characterises disease flares. Genetic variants in the IL-21/IL-21R pathway are SLE risk alleles (see Sanz2025 - Human Atypical B Cells Overview, review).

  • IL-21 is the cytokine that induces the CD11c arm of the ABC phenotype. In the ABC differentiation programme, IL-21 robustly induces CD11c while IFN-γ primarily drives T-bet — a division of labour between the two cytokines that, together with TLR7/9, generate age-associated B cells. IL-21 also drives expansion and plasma-cell differentiation of autoreactive CD11c^hi T-bet⁺ B cells, and IL-21-inducible genes are strongly upregulated in ABC transcriptomes (see Lamprinou2026 - ABCs and DN B Cells, opinion, citing Naradikian 2016 / Liu 2024 / Wang 2018; Age-Associated B Cell).

  • IL-21 is one of three required signals for ABC differentiation, alongside endosomal TLR signalling and IFN-γ. Atypical B cells are described as arising from BCR stimulation in an inflammatory cytokine milieu, “with their differentiation requiring additional signals from endosomal TLRs, as well as from IFN-γ and IL-21” (see Glaros2025 - Multilayered Identity of B Cell Memory, review, no original data, citing a large mouse and in vitro literature). Independently restates the differentiation programme the wiki carries from Jenks2018 - DN2 B Cells and EF Pathway in SLE and Lamprinou2026 - ABCs and DN B Cells.

  • IL-21 drives plasma-cell differentiation from CD11c^hi T-bet⁺ B cells — evidence that ABCs are PC-competent. Among the primaries the review cites for ABCs being “transcriptionally and functionally primed for PC differentiation” is a study showing IL-21 drives expansion and plasma-cell differentiation of autoreactive CD11c^hi T-bet⁺ B cells in SLE (citing Wang 2018 Nat Commun), together with increased PC propensity in T cell coculture generally (review). This is directly parallel to the dengue Tph→IL-21→plasmablast axis (Ansari2025 - Peripheral T Helper Subset Drives B Cell Response in Dengue) and to the IL-21-blocking result that reduced PB output ~60%.

  • A different cytokine, IL-21’s relative IL-9, governs GC-derived memory formation. The transcriptional repressor ZBTB18 is induced in GC-derived MBC precursors by IL-9, and IL-4 has been reported to both promote and suppress GC-derived MBC development depending on timing (see Glaros2025 - Multilayered Identity of B Cell Memory, review). Noted for contrast: the cytokine controlling GC memory exit is distinct from the IL-21/IFN-γ axis controlling the atypical/EF programme.

  • IL-21 is one of two cytokine signals (with IFN-γ) that convert TLR-poised B cells to ABC fate — and IL-4 antagonises it conditionally. In the two-signal ABC model, TLR7/9 poising must be followed by IFN-γ or IL-21 to complete ABC differentiation. IL-4 negatively regulates the T-bet⁺ ABC fate specifically in the context of IL-21, but does not block the IFN-γ-driven route. In vivo: ABCs formed during WT influenza infection (Th1, IFN-γ-dominant) but failed in IFN-γ-deficient mice, yet returned in IFN-γ/IL-4 double-deficient mice; conversely, ABCs failed to form during WT Heligmosomoides polygyrus infection (Th2, IL-4-dominant) but arose robustly in IL-4-deficient mice — removing IL-4 unmasks an IL-21-driven, IFN-γ-independent route to ABC fate (see Cancro2020 - Age-Associated B Cells, review — no original data; mouse, knockout).

  • IL-21-dependence of autoimmune ABC expansion confirmed genetically: SWEF IL-21-deficient double-knockouts develop neither expanded ABCs nor autoantibodies. In the SWEF lupus model, ABC expansion is strongly IL-21-driven; IL-21-deficient SWEF double-knockout mice developed neither ABC expansion nor autoantibodies. This IL-21-driven expansion relies on IRF5 (plain text — no wiki page), an established human SLE risk gene (see Cancro2020 - Age-Associated B Cells, review — no original data; mouse, knockout).

  • IL-21 (with TLR7/9) drives rapid ABC→ASC differentiation, and rescues TLR9-tolerance-arrested cells into the ABC phenotype. ABCs differentiate rapidly into antibody-secreting plasmablasts on TLR7/9 stimulation plus IL-21 (citing Wang 2018 and Jenks2018 - DN2 B Cells and EF Pathway in SLE). Separately, when B cells receiving a BCR-delivered TLR9 ligand would otherwise undergo programmed death, survival cytokines or CD40 costimulation rescue them — and in the presence of IFN-γ or IL-21, the rescued cells assume the ABC phenotype (Sindhava et al. 2017, cited in Cancro2020 - Age-Associated B Cells, review — no original data; mouse). This places IL-21 at both the differentiation step and the tolerance-rescue step of the ABC pathway.

  • ★ IL-21 is obligate for ASC formation but acts late, and its receptor is what IFN-γ pre-installs. No ASCs formed at all in cultures lacking IL-21. Timing is decisive: IL-21 present only during days 0–3 gave normal pre-ASCs but no ASCs, while IL-21 only during days 3–6 was as effective as IL-21 throughout — late IL-21 is sufficient. IFN-γ priming raises IL-21R protein 5.5–6-fold by day 6 (MFI 163 without IFN-γ vs 1047 with) and opens a DAR in the IL21R locus that is also present in SLE patient T-bet^hi^ DN2 cells (see Zumaquero2019 - IFN-gamma Programs T-bet-hi B Cells for ASC Differentiation, human, n=20 HD + n=40 SLE + in vitro reconstruction). So IL-21 is the differentiation trigger, not the priming signal — and a cell’s IL-21 responsiveness is set earlier, by IFN-γ. ⚠ Note the disconnect with the patient data in the same paper: plasma IL-21 did not correlate with T-bet^hi^ DN2 frequency (r=0.087, ns) despite being functionally required in vitro, consistent with IL-21 acting by local delivery rather than circulating concentration.

  • ⚠ Song2022 is not evidence that IL-21 drives T-bet⁺CD11c⁺/ABC generation — the cytokine was inferred from cell position and never measured. The paper establishes that Tfh, not Th1, are required, and that help is delivered in spatial proximity at the follicular edge, then suggests this “could include cytokines such as IL-21 and IFN-γ”. Assessing Tfh effector molecules is listed as the study’s first limitation (see Song2022 - Tfh Outside Germinal Centers Drive T-bet CD11c B Cells, mouse, LCMV-Armstrong; inference, not measurement). This matters because the IL-21 → DN2/ABC axis on this page is otherwise supported by direct evidence (Jenks2018 - DN2 B Cells and EF Pathway in SLE, Zumaquero2019 - IFN-gamma Programs T-bet-hi B Cells for ASC Differentiation), and it would be easy to read Song’s Tfh-dependence as adding to it. It establishes the cell, not the molecule.

Contradictions & Debates

None documented in current wiki sources.

Peripheral Helper T Cell, Extrafollicular Response, Plasmablast, DN2 B Cell, Age-Associated B Cell, Activated Naive B Cell, TLR7, CD11c, T-bet, BLIMP-1, IRF4, Memory B Cell, Atypical B Cell, Age-Associated B Cell, T-B Coculture Assay

Sources

Graph View

Backlinks